UZ Leuven
Leuven, 3000, Belgium
Location status: Recruiting
Location contact
Brecht Geysenbergh, MD
CONTACT
Myriam Welkenhuysen
CONTACT
NCT Number: NCT03900780
Assessing whether Preimplantation Genetic Testing for Aneuploidy (PGT-A) can increase the ongoing pregnancy rate per transferred embryo and can decrease the time to pregnancy and miscarriage rate in patients with Recurrent Implantation Failure (RIF)
Interested in participating?
Request Info18 year–40 year
Female
Interventional
Not applicable
Leuven, 3000, Belgium
Location status: Recruiting
Brecht Geysenbergh, MD
CONTACT
Myriam Welkenhuysen
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ovarian stimulation, oocyte aspiration, embryo culture until the blastocyst stage (day 5/6), TE biopsy, vitrification of all embryos in the blastocyst stage, PGT-A by NGS and finally embryo transfer of genetically normal embryos in cumulative frozen-thawed embryo transfer cycles
ovarian stimulation, oocyte aspiration, embryo culture until the blastocyst stage, fresh embryo transfer of the morphologically best embryo on day 5/6, vitrification of supernumerary embryos and embryo transfer in cumulative frozen-thawed embryo transfer cycles if not pregnant from the fresh cycle.
Time frame: at 20 weeks gestational age
Ongoing pregnancy rate per embryo transfer
Time frame: 2 weeks
Implantation rate per transferred embryo
Contact information is provided by the study sponsor or research team.
Universitaire Ziekenhuizen KU Leuven
Other
Preimplantion Genetic Testing for Aneuploidies (PGT-A) in Patients With Recurrent Implantation Failure: a Pilot RCT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05169541
Abortion, Habitual, Abortion, Spontaneous
Aarhus, Denmark
View Trial DetailsNCT05343572
Asherman Syndrome, Atrophic Endometrium
Orange, Connecticut, United States
View Trial DetailsNCT06762626
Genital Diseases, Infertility
Hong Kong, China
View Trial DetailsNCT07641088
Recurrent Implantation Failure
Hefei, Anhui, China
View Trial Details